Full Text View
Tabular View
No Study Results Posted
Related Studies
Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation
This study has been completed.
Study NCT01542138   Information provided by Universidad Autonoma de San Luis Potosí

First Received on February 21, 2012.   Last Updated on November 27, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperpigmentation
More general conditions related to this trial
Pigmentation Disorders
Skin Diseases
Interventions listed in this trial
Desonide
Niacinamide
Placebo
Additional drug interventions recognized in this trial
Niacin
Nicotinic Acids
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antimetabolites
Cardiovascular Agents
Growth Substances
Hypolipidemic Agents
Lipid Regulating Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Universidad Autonoma de San Luis Potosí
Hospital Central "Dr. Ignacio Morones Prieto"


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services